Such a differential expression pattern was not detected between Th1 and Th17 lymphocytes from RA patients, either before or after adalimumab therapy; in addition, the levels of TNFR2 on both T cell subsets were equivalent between controls and patients before or after therapy (Figure 7C). This evidence concerns the gene TNFRSF1B and rheumatoid arthritis.